A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
The objective of this study is to evaluate the safety and efficacy of ONO-4641 in patients with relapsing-remitting multiple sclerosis over a 26-week treatment period.
Inclusion Criteria:
Exclusion Criteria:
HighPoint, North Carolina 27265, United States
British Columbia, V6T 2B5, Canada
Kanto, Japan
Kanto, Japan
Kanto, Japan
Kanto, Japan
Kinki, Japan
Kinki, Japan
Kinki, Japan